Serology for Trachoma Surveillance after Cessation of Mass Drug Administration

Abstract

Serologic tests support NAAT findings of very low to zero prevalence of ocular Ct in this community and have potential to provide objective measures of transmission and useful surveillance tools for trachoma elimination programs.